Navigation Links
Herpes Drug Might Also Slow HIV Progression
Date:2/15/2010

But acyclovir is not a replacement for HIV-specific drugs, researchers say

MONDAY, Feb. 15 (HealthDay News) -- New research suggests that people who are infected with both HIV-1, a strain of the AIDS virus, and herpes simplex virus type 2 could benefit in more than one way by taking a herpes drug called acyclovir. In addition to treating herpes, the medication appears to also slow the progression of HIV.

"While the HIV-disease ameliorating effect we have observed is modest, it could add one more tool to help people with HIV infection stay healthy for longer," study co-author Dr. Jairam Lingappa, of the University of Washington, said in a news release from The Lancet.

The study, published online in the journal, analyzed what happened to almost 3,400 people in Africa who were infected with both diseases.

Half were assigned to take 400 milligrams of acyclovir twice a day, and the others took a placebo. Researchers tracked their progress for up to 24 months.

The risk of HIV progression was reduced by 16 percent in those who took acyclovir, the study found.

However, other research has suggested that acyclovir does not prevent transmission of HIV to heterosexual partners by people who take the drug, the scientists said.

The researchers said that other AIDS drugs would have a greater impact on the progression of HIV in those who were infected. But , acyclovir could be an option for people who had not progressed far enough to need antiretroviral therapy, they said.

More information

The U.S. Centers for Disease Control and Prevention has more on herpes.



-- Randy Dotinga



SOURCE: The Lancet, news release, Feb. 14, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Genital Herpes Reactivation Better Understood
2. Control of herpes symptoms does not reduce HIV transmission, international study found
3. Study shows genital herpes virus reactivates widely throughout genital tract
4. Herpes medication does not reduce risk of HIV transmission, UW-led international study finds
5. Genital Herpes May Never Go Dormant
6. VivaGel(R) Demonstrates Anti-HIV and Herpes Activity Following Human Administration
7. Scientists learn why even treated genital herpes sores boost the risk of HIV infection
8. Condoms May Reduce Herpes Risk
9. Herpes medication does not reduce risk of HIV transmission
10. Treatment Target for Herpes Pinpointed
11. Herpes: Scientists find cellular process that fights virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... Ongoing news ... Aging Life Care Association™ (ALCA) to conduct a survey that takes a closer look ... released today illustrates the prevalence and causes of TBI among the aging population, and ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... welcomes S.S. Nesbitt as the latest addition to its growing list of Partner ... locations throughout the Southeast, from Orlando to Huntsville and in between. , Harnessing ...
(Date:2/10/2016)... ... February 10, 2016 , ... AxoGen, Inc. (NASDAQ: AXGN), a leading ... the fourth quarter and full year ended December 31, 2015 on Monday, February 29, ... webcast for the investment community following the release at 4:30 PM ET. Investors interested ...
(Date:2/10/2016)... ... February 10, 2016 , ... AHRA: The Association ... inspirational speaker Jan Fox will serve as keynote speaker at the organization’s 2016 ... with tools to more effectively communicate with their own organizational staff and leadership. ...
(Date:2/10/2016)... ... February 10, 2016 , ... For additional information contact Phyllis Strupp 480-488-5858 , ... with Age: The Ultimate Guide to Brain Training" by award-winning author Phyllis Strupp ... publication date is March 16, 2016. A free review copy is available to ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... 9, 2016 On Tuesday, February ... met with its Arthritis Advisory Committee to ... Johnson & Johnson,s Remicade and most likely ... the U.S. The Biologics Prescribers Collaborative (BPC) ... Alliance for Patient Access, American Association of ...
(Date:2/10/2016)... February 10, 2016 The campaign aims ... 5 years reach the milestone of their 5 th ... ensure 2,50,532 children between the ages of 2 - 5 ... --> The campaign aims to ... reach the milestone of their 5 th birthday   ...
(Date:2/9/2016)... FARMINGDALE, N.Y., Feb. 9, 2016  Misonix, Inc. ... company that designs, manufactures and markets innovative therapeutic ... wound debridement, cosmetic surgery, laparoscopic surgery and other ... second quarter and the first half of fiscal ... --> --> Highlights ...
Breaking Medicine Technology: